person

Rémy L.

Country
France
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
66
Sites with multiple studies

Has run more than one trial at 66 of 185 partner sites.

Specializations

Gynecologic Oncology

This investigator specializes in the treatment of advanced ovarian cancer, with particular focus on combination therapy approaches involving bevacizumab and niraparib. Their research extends to peritoneal cancer and fallopian tube cancer management.

  • Advanced ovarian cancer therapies
  • Post-surgical treatment strategies
  • Maintenance therapy protocols

The investigator explores innovative treatment combinations for patients following complete cytoreductive surgery.

Breast Cancer Research

The investigator focuses on treating hormone receptor-positive HER2-positive metastatic breast cancer, exploring novel therapeutic combinations including palbociclib with anti-HER2 therapy and endocrine therapy.

  • Metastatic breast cancer treatment
  • Targeted combination therapies
  • Hormone receptor-positive disease management

Their work centers on developing effective treatment strategies for previously untreated metastatic breast cancer patients.

Endometrial Cancer

The investigator studies treatment approaches for MMR deficient endometrial cancer, particularly in advanced and metastatic settings. Their research includes evaluation of dostarlimab therapy compared to conventional chemotherapy approaches.

  • Advanced endometrial cancer treatment
  • Immunotherapy applications
  • First-line therapy optimization

The research focuses on improving survival outcomes for patients with advanced endometrial cancer.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.